This is the authors' abstract. We don't add key points for this paper.
This study compared the efficacy of unilateral dual-channel endoscopy (UBE-TLIF) with minimally invasive transforaminal lumbar fusion (MIS-TLIF) in the treatment of lumbar tuberculosis. Thirty-eight patients from 2019 to 2024 were retrospectively analyzed and divided into UBE-TLIF group (20 patients) and MIS-TLIF group (18 patients). There was no statistically significant difference between the baseline data of the two groups. The results showed that the UBE-TLIF group had shorter operation time ( P < 0.05), less intraoperative bleeding ( P < 0.05), and shorter hospitalization time ( P < 0.05). For postoperative complications, two dural sac tears occurred in the UBE-TLIF group and two nerve root traction injuries in the MIS-TLIF group, both of which recovered with conservative treatment. At a mean follow-up of 16 months, The mean follow-up period was15.8 ± 3.1 months in the MIS-TLIF group and16.2 ± 2.9 months in the UBE group, with no statistically significant difference between the groups( P = 0.674),no tuberculosis recurrence or implant loosening was observed in either group. Postoperative VAS(Visual Analogue Scale) low back pain scores were significantly better in the UBE-TLIF group than in the MIS-TLIF group at 1 and 3 months ( P < 0.05), but the difference between the two groups disappeared at 6 months and at the final follow-up. ODI(Oswestry Disability Index), intervertebral space height and inflammatory indexes (blood sedimentation, C-reactive protein, calcitoninogen) were significantly improved after surgery ( P < 0.05), with no difference between groups. At the final follow-up, there was no statistically significant difference between the two groups in terms of bone fusion rate and MacNab efficacy evaluation (P > 0.05). Both surgical approaches proved effective, but UBE-TLIF demonstrated certain advantages in operative time, intraoperative blood loss, and early postoperative pain control, making it a preferred option for the surgical treatment of spinal tuberculosis. This study confirms the safety and feasibility of combining minimally invasive techniques with standardized anti-tuberculosis therapy, offering a new alternative for clinical practice.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Abudurezhake et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: